title: Efficacy of Lansap combination therapy for eradication of H. pylori.
authors.forename: Akihito
authors.initials: A
authors.lastname: Nagahara
authors.forename: Hiroto
authors.initials: H
authors.lastname: Miwa
authors.forename: Mariko
authors.initials: M
authors.lastname: Hojo
authors.forename: Takashi
authors.initials: T
authors.lastname: Yoshizawa
authors.forename: Masato
authors.initials: M
authors.lastname: Kawabe
authors.forename: Taro
authors.initials: T
authors.lastname: Osada
authors.forename: Akihiko
authors.initials: A
authors.lastname: Kurosawa
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Ohkusa
authors.forename: Sumio
authors.initials: S
authors.lastname: Watanabe
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017291:Clarithromycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance
chemical_list: D000900:Anti-Bacterial Agents; D017291:Clarithromycin